Clinical Trial Update: Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aldosterone blockade for health improvement in end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Aldosterone receptor antagonist (mineralocorticoid receptor antagonist)

Snippet

Sponsor: Population Health Research Institute | Conditions: Endstage Renal Disease | Phase 3 | Status: COMPLETED